As pouched products increase in popularity, researchers assess their pharmacology, harm-reduction potential, and initiation risk.
|Articles|December 1, 2012
Drug Topics, Digital Edition, December 2012
36 Dead From Meningitis Outbreak : Will the Valid Compounding Act be able to avert such a tragedy from happening again? Insulin therapy for diabetes care management Seize the day : Provide patient care Push provider status for pharmacists A tragic lesson in risk management
Advertisement
Advertisement
Related to this article
The approval is the first new treatment advance in more than 30 years for chronic kidney disease for adults with type 1 diabetes.
Adults with serious mental illness receive GLP-1 prescriptions at rates similar to or higher than their peers, though schizophrenia continued to lag.
Madeline Sutton, MD, MPH, FACOG, joins to discuss risks of HPV infection among women and how pharmacists can improve outcomes in this area.
In part 2, Vanessa Slowey explains the pharmacy industry’s need for due diligence as technology reinforces patient convenience in the 21st century.
A study found that age and physical comorbidities—not psychiatric diagnosis—were associated with nonpsychotropic polypharmacy.
As pharmacists vocalize their willingness to fill in health care gaps, the integration of public health and emerging pharmacy professionals could be profound.
The expert explains 2025-1016 flu, COVID-19, and RSV vaccine updates from AAP, ACOG, AAFP, and IDSA, and what changing schedules mean for pharmacists.
Advertisement
Advertisement
Trending on Drug Topics
1
GLP-1 Prescribing Rose Among Adults With Serious Mental Illness
2
Scripted for Her: The Pharmacist's Role in HPV Prevention
3
AI, Automation Are Transforming Pharmacies into Proactive Care Hubs
4
Study Links Age and Comorbidities to Polypharmacy in Patients With Mental Illness
5